Revance Therapeutics Inc. buy quelbe60
Start price
29.11.24
/
50%
€3.42
Target price
29.11.25
-
Performance (%)
3.51%
End price
05.12.24
€3.54
Summary
This prediction ended on 05.12.24 with a price of €3.54. The BUY prediction by quelbe60 finished with a performance of 3.51%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
According to quelbe60 what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by quelbe60 for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.